|
LO-1
|
will be able to evaluate the pharmacokinetic factors altering drug-induced effects in geriatric patients. |
|
LO-2
|
evaluate the pharmacodinamic factors altering drug-induced effects in geriatric patients. |
|
LO-3
|
discuss possible risks of unsuitable drug use in geriatric patients. |
|
LO-4
|
distinguish safe drug groups in geriatric patients. |